Oncology Contact Us

Exploring New Possibilities in Kidney Cancer Detection and Therapy

A user-friendly “nudge” may provide a timely reminder to surgeons to consider the value of sentinel lymph node biopsy in older patients with breast cancer.

Experts discuss findings related to liquid biopsy profiling, later-line immunotherapy, and CDK4/6 inhibitor efficacy presented at the 2024 KCRS meeting.

Karl Semaan, MD, MSc ;Neil J. Shah, MBBS;Bradley McGregor, MD

July 22nd 2024

27 CARDIAC-STAR: Prevalence of Cardiovascular (CV) Comorbidities in Hormone Receptor–Positive/ Human Epidermal Growth Factor Receptor 2–Negative (HR+/HER2–) Metastatic Breast Cancer (mBC)

Experts discuss findings related to liquid biopsy profiling, later-line immunotherapy, and CDK4/6 inhibitor efficacy presented at the 2024 KCRS meeting.

Heather Moore;Avirup Guha;Doris Makari;Rachael McCaleb;Irene Arias;Stella Stergiopoulos;Benjamin Li;Michael Fradley;Susan Dent, MD

Overcoming Physical and Social Barriers in the Lymphoma Field

Leaders from the lymphoma space highlight the importance of mentorship in establishing their careers and impart advice to women looking to advance theirs.

Julie M. Vose, MD, MBA;Avyakta Kallam, MD

July 15th 2024

Ozuriftamab Vedotin Gains FDA Fast Track Designation for Recurrent SCCHN

Leaders from the lymphoma space highlight the importance of mentorship in establishing their careers and impart advice to women looking to advance theirs.

Multiple confirmed responses in a phase 2 trial support the FDA designation for the experimental therapy in squamous cell carcinoma of the head and neck.

Roman Fabbricatore

Creating Confidence While Climbing the Ranks in the Lymphoma Field

Multiple confirmed responses in a phase 2 trial support the FDA designation for the experimental therapy in squamous cell carcinoma of the head and neck.

Ariana Pelosci

Electronic Intervention May Decrease Low-Value Surgery in Breast Cancer

“Sometimes you have to be a little more assertive and a little louder, and you have to step up to the front,” Julie M. Vose, MD, MBA, said.

Related Content

Russ Conroy

July 26th 2024

Exploring New Possibilities in Kidney Cancer Detection and Therapy

A user-friendly “nudge” may provide a timely reminder to surgeons to consider the value of sentinel lymph node biopsy in older patients with breast cancer.

Karl Semaan, MD, MSc ;Neil J. Shah, MBBS;Bradley McGregor, MD

July 22nd 2024

27 CARDIAC-STAR: Prevalence of Cardiovascular (CV) Comorbidities in Hormone Receptor–Positive/ Human Epidermal Growth Factor Receptor 2–Negative (HR+/HER2–) Metastatic Breast Cancer (mBC)

Experts discuss findings related to liquid biopsy profiling, later-line immunotherapy, and CDK4/6 inhibitor efficacy presented at the 2024 KCRS meeting.

Heather Moore;Avirup Guha;Doris Makari;Rachael McCaleb;Irene Arias;Stella Stergiopoulos;Benjamin Li;Michael Fradley;Susan Dent, MD

Overcoming Physical and Social Barriers in the Lymphoma Field

Julie M. Vose, MD, MBA;Avyakta Kallam, MD

July 15th 2024

Ozuriftamab Vedotin Gains FDA Fast Track Designation for Recurrent SCCHN

Leaders from the lymphoma space highlight the importance of mentorship in establishing their careers and impart advice to women looking to advance theirs.

Roman Fabbricatore

Creating Confidence While Climbing the Ranks in the Lymphoma Field

Multiple confirmed responses in a phase 2 trial support the FDA designation for the experimental therapy in squamous cell carcinoma of the head and neck.

Ariana Pelosci